| Literature DB >> 21071927 |
Abstract
Direct-to-consumer personal genome testing is now widely available to consumers. Proponents argue that knowledge is power but critics worry about consumer safety and potential harms resulting from misinterpretation of test information. In this article, we consider the health system implications of direct-to-consumer personal genome testing, focusing on issues of accountability, both corporate and professional.Mesh:
Substances:
Year: 2010 PMID: 21071927 PMCID: PMC3025885 DOI: 10.1159/000321962
Source DB: PubMed Journal: Public Health Genomics ISSN: 1662-4246 Impact factor: 2.000